Andrew Donald Nash

This inventor holds 29 USPTO granted patents and 12 published patent applications, plus 8 CIPO patents and 13 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Csl Limited, Zenyth Operations Pty. Ltd., Csl Behring Gmbh. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Donald Nash. Retrieved from https://idiyas.com/inventor/andrew-donald-nash

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 12)

% Patents Active = 86.2

CIPO Patents = 8

EPO Patents = 13 (Patent Applications = 7)

Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 72(Granted Patents)

Location History:

Northcote, AU (2007)
Victoria, AU (2013)
Kew, AU (2007 - 2022)
Parkville, AU (2015 - 2024)

Company Filing History:

Zenyth Operations Pty. Ltd.

Walter and Eliza Hall Institute of Medical Research

where one patent can have more than one assignee

Years Active: 2007-2024

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

G-CSF Receptor

IL-13 Antagonists

Factor XII

Cytokine Signalling

VEGF-B Antagonist

Lupus Treatment

Pulmonary Disease

Interferon Cells

Inhibitory Antibodies

Haemopoietin Receptor

Immunointeractive Molecules

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12071484 - Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein (2024-08-27),

2. 11345759 - Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies (2022-05-31),

3. 10513560 - Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies (2019-12-24),

4. 10106617 - High affinity antibody antagonists of interleukin-13 receptor alpha 1 (2018-10-23),

5. 9856326 - Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies (2018-01-02),

6. 9856325 - Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodies (2018-01-02),

7. 9777062 - High affinity antibody antagonists of interleukin-13 receptor alpha 1 (2017-10-03),

8. 9758585 - Compositions and methods for targeting type 1 interferon producing cells (2017-09-12),

9. 9518127 - Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses (2016-12-13),

10. 9376682 - Method of treating pulmonary disease by administering an antibody to G-CSF (2016-06-28),

11. 9371388 - High affinity antibody antagonists of interleukin-13 receptor alpha 1 (2016-06-21),

12. 9193793 - Antibodies against G-CSFR and uses thereof (2015-11-24),

13. 9085628 - Antibody molecule for human GM-CSF receptor alpha (2015-07-21),

14. 8822644 - Method of treating cancer comprising a VEGF-B antagonist (2014-09-02),

15. 8613925 - Anti-IL-13Rα1 antibodies and their uses thereof (2013-12-24),

Title: The Innovative Journey of Andrew Donald Nash

Introduction: Andrew Donald Nash, a pioneering inventor hailing from Parkville, Australia, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Andrew Nash's latest patents include a cutting-edge wearable device for monitoring health metrics in real-time and a revolutionary software application designed to streamline communication in the workplace.

Career Highlights: With a career spanning over two decades, Andrew Nash has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on various industries.

Collaborations: Throughout his career, Andrew Nash has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: Andrew Donald Nash's relentless pursuit of innovation and his passion for creating technology that enhances lives have solidified his position as a prominent figure in the world of inventors. His dedication to pushing the boundaries of what is possible continues to inspire future generations of innovators.

Profile summary based on public USPTO records.